Search

Your search keyword '"Espinosa, Nuria"' showing total 244 results

Search Constraints

Start Over You searched for: Author "Espinosa, Nuria" Remove constraint Author: "Espinosa, Nuria"
244 results on '"Espinosa, Nuria"'

Search Results

1. The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers

2. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

3. Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypes

5. Rat hepatitis E virus (Rocahepevirus ratti) in people living with HIV

6. Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort

7. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

8. Rat hepatitis E virus (Rocahepevirus ratti) in people living with HIV.

9. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

10. Repeated Pulses of Methyl-Prednisolone in Adults Hospitalized With COVID-19 Pneumonia and Acute Respiratory Distress Syndrome: A Preliminary Before–After Study (CortiCOVID Study)

11. This title is unavailable for guests, please login to see more information.

12. Plasma concentrations of IL-6, MIP-1β, IP-10, and PTX-3 as predictors of the immunological response to antiretroviral treatment in people with HIV.

13. Long-term effects on immunological, inflammatory markers, and HIV-1 reservoir after switching to a two-drug versus maintaining a three-drug regimen based on integrase inhibitors.

14. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

15. Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile

16. Rat hepatitis E virus (Rocahepevirus ratti) in people living with HIV [Dataset]

17. High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world

22. Rat hepatitis E virus ( Rocahepevirus ratti ) in people living with HIV

23. Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019–2021

24. Impact of Treatment Adherence on Efficacy of Dolutegravir + Lamivudine and Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Week 144 Analysis of the GEMINI-1 and GEMINI-2 Clinical Studies

26. Immunological and inflammatory changes after simplifying to dual therapy in virologically suppressed HIV-infected patients through week 96 in a randomized trial

28. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

29. Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV

31. Darunavir/cobicistat showing similar effectiveness as darunavir/ritonavir monotherapy despite lower trough concentrations

32. Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV

33. Prevalence of non-alcoholic fatty liver disease in a multicentre cohort of people living with HIV in Spain

34. Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered

36. Cardiometabolic Parameters 3 Years After Switch to Dolutegravir/Lamivudine vs Maintenance of Tenofovir Alafenamide–Based Regimens.

38. TLR Agonists Enhance HIV-Specific T-Cell Response Mediated by Plasmacytoid Dendritic Cells in Diverse HIV-1 Disease Progression Phenotypes

39. Transcripción simultánea de voz a texto en el aula como medio de inclusión lingüística

41. Toll-like Receptor Agonists Enhance HIV-specific T Cell Response Mediated by Plasmacytoid Dendritic Cells in Diverse HIV-1 Disease Progression Phenotypes

42. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

43. Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered.

45. Incidence Rate and Risk Factors for Anal Squamous Cell Carcinoma in a Cohort of People Living With HIV from 2004 to 2017: Implementation of a Screening Program

46. High-resolution anoscopy in HIV-infected men: Assessment of the learning curve and factors that improve the performance

47. Phenotypic plasticity of Monilinia spp. in response to light wavelengths: From in vitro development to virulence on nectarines

48. Uso de pulsos de metilprednisolona de repetición en adultos hospitalizados por neumonía y síndrome de distrés respiratorio agudo por COVID-19: un estudio preliminar de tipo antes-después (estudio CortiCOVID)

49. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection

50. eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort

Catalog

Books, media, physical & digital resources